Provided by Tiger Trade Technology Pte. Ltd.

Tectonic Therapeutic, Inc.

22.63
-0.0400-0.18%
Volume:50.42K
Turnover:1.14M
Market Cap:442.40M
PE:-4.95
High:23.07
Open:22.73
Low:22.14
Close:22.67
52wk High:39.53
52wk Low:14.60
Shares:19.55M
Float Shares:12.20M
Volume Ratio:0.44
T/O Rate:0.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.5678
EPS(LYR):-4.0500
ROE:-33.80%
ROA:-22.29%
PB:1.98
PE(LYR):-5.59

Loading ...

Tectonic Therapeutic Currently Down 13 Days Straight, on Pace for Record Losing Streak

Dow Jones
·
21 hours ago

Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), Tectonic Therapeutic (TECX)

TIPRANKS
·
Sep 30

FDA Grants Tectonic Tx2100 Fast Track Status for HHT

Reuters
·
Sep 30

Tectonic Therapeutic on Track for Longest Losing Streak Since November 2021

Dow Jones
·
Sep 30

Analyst Maintains Buy on TECX as TX2100 Advaces on Compressed Path to Proof-of-Concept; $88 Price Target Unchanged

TIPRANKS
·
Sep 29

Tectonic Therapeutic Reports Favorable Phase 1a Results for Tx2100 in HHT Program

Reuters
·
Sep 29

Tectonic Therapeutic, - Tx2100 Trial Reported Only Mild or Moderate Transient Adverse Events; no Deaths or Serious Events

THOMSON REUTERS
·
Sep 29

Tectonic Therapeutic, - FDA Grants Fast Track Designation for Tx2100 in Hht and Clears Ind for Phase 1B Trial

THOMSON REUTERS
·
Sep 29

Tectonic Therapeutic, - Tx2100 Phase 1a Trial Shows Single Ascending Doses Generally Safe and Well-Tolerated

THOMSON REUTERS
·
Sep 29

Tectonic Therapeutic, - Plans to Initiate Tx2100 Phase 1B Trial by Year-End 2026 and Phase 2 in Early 2027

THOMSON REUTERS
·
Sep 29

Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and Pk Results for Tx2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (Hht)

THOMSON REUTERS
·
Sep 29

Tectonic Therapeutic, - Pk Results Support Once Weekly and Every Other Week Subcutaneous Dosing Regimens

THOMSON REUTERS
·
Sep 29

Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference

GlobeNewswire
·
Sep 03

Tectonic Therapeutic (TECX) Gets a Buy from Oppenheimer

TIPRANKS
·
Sep 01

Tectonic Therapeutic (TECX) Receives a Buy from Piper Sandler

TIPRANKS
·
Aug 31

Tectonic Therapeutic CSO Peter McNamara Disposes of USD 1,570.36 in Common Shares

Reuters
·
Aug 27

Tectonic Therapeutic CSO Peter McNamara Reports TECX Common Share Disposal Worth $1,505 on Aug. 12

Reuters
·
Aug 15

Truist Financial Sticks to Its Buy Rating for Tectonic Therapeutic (TECX)

TIPRANKS
·
Aug 10

Piper Sandler Sticks to Its Buy Rating for Tectonic Therapeutic (TECX)

TIPRANKS
·
Aug 07

Tectonic Therapeutic Q2 EPS $(1.18) Beats $(1.37) Estimate

Benzinga Earnings
·
Aug 07